Ronald Harold Wilfred Cooper insider trades

Open-market stock purchases and sales by Ronald Harold Wilfred Cooper, Director at C4 Therapeutics, Inc, from SEC Form 4 filings since Jun 7, 2016.

Recent trades

DateStockTradeValue
Jun 24, 2026CCCC C4 Therapeutics, IncBought (not open market)—
Feb 9, 2026GBIO Generation Bio CoSold (not open market)$1.2M
Feb 9, 2026GBIO Generation Bio CoSold (not open market)$119K
Feb 9, 2026GBIO Generation Bio CoSold (not open market)$121K
Feb 9, 2026GBIO Generation Bio CoSold (not open market)$199K
Feb 9, 2026GBIO Generation Bio CoSold (not open market)—
Jan 30, 2026ENGN enGene Holdings IncBought (not open market)—

Companies traded

  • CCCC C4 Therapeutics, Inc: other filings, last Jun 24, 2026
  • GBIO Generation Bio Co: other filings, last Feb 9, 2026
  • ENGN enGene Holdings Inc: 1 buy, last Jan 30, 2026
  • ALBO Albireo Pharma, Inc: 3 buys, 6 sales, last Mar 2, 2023
  • GNCA Genocea Biosciences, Inc: other filings, last Jun 18, 2020

Get free alerts when Ronald Harold Wilfred Cooper files a new trade →